The Quality of Life in Individuals With Parkinson's Disease

Pamukkale University

Status: Completed

Conditions: Tremor; Functionality; Parkinson Disease

Treatments: Other: Tremor amplitude; Other: Clinical manifestations; Other: Quality of life; Other: Grip and pinch strength; Other: Upper limb functionality; Other: Depression and anxiety levels

Study type: Observational

Funder types: Other

Identifiers

NCT05906693

2019SABE021 (Other Grant/Funding Number)

60116787-020/45991

Details and patient eligibility

About

This study aimed to examine the relationship of quality of life with tremor severity and upper limb functionality in individuals with Parkinson's Disease. The differences between Parkinson's Disease Quality of Life Questionnaire, Nine-Hole Peg Test, grip and pinch strength values in the individuals with and without tremor in the study were investigated.

Full description

Evaluating the relationship between Quality of Life and tremor is needed to determine the best physiotherapy and rehabilitation approaches for individuals with Parkinson's Disease. This study aimed to examine the relationship of quality of life with tremor severity and upper limb functionality in individuals with Parkinson's Disease. Fifty-two individuals with Parkinson's Disease participated in the study. Quality of Life, tremor amplitude, upper limb functionality, grip and pinch strength were evaluated. The relationship of quality of life with tremor severity and upper limb functionality was examined in individuals with Parkinson's Disease. The results of individuals with and without tremor were compared.

Enrollment: 52 patients

Sex: All

Ages: 40 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Definite diagnosis of idiopathic Parkinson Disease
• Age between 40 and 80 years
• Being literate
• Having a grade between 1-4 from the Modified Hoehn and Yahr Scale
• Having a score lower than 11 in Hospital Anxiety and Depression Scale

Exclusion criteria

• Who were with any other neurologic or orthopedic or rheumatologic disease affecting the upper extremity
• Using antidepressants
• Having vision loss
• Deep brain stimulation

Trial design